Skip to main content

Advertisement

Table 4 Results, discussion and conclusions concerning efficacy

From: Questions asked and answered in pilot and feasibility randomized controlled trials

   Drug (n = 28) Non-drug (n = 22)
ABSTRACT    
   Take home message no mention of efficacy 4 (14%) 4 (18%)
  not shown to have benefit/no benefit 4 (14%) 1 (5%)
  intervention shows promise 8 (29%) 5 (23%)
  intervention beneficial 12 (43%) 12 (55%)
Mentioned that further/larger trials needed 13 (46%) 11 (50%)
RESULTS    
   Statistically significant none 12 (43%) 9 (43%)
   results relating to efficacy within groups only 5 (18%) 4 (19%)
  between groups 11 (39%) 8 (38%)1
DISCUSSION    
   Extent of discussion about minimal 1 (4%) 3 (14%)
   efficacy substantial 11 (39%) 9 (41%)
  major focus of section 16 (57%) 10 (46%)
Mentioned that the sample size was too small 24 (86%) 19 (88%)
  1. 1 - One paper reporting a non-drug trial didn't report any significance tests or confidence intervals and was excluded from these figures